131
Prostate cancer tissue array with unmatched normal prostate tissues, 24 cases/48 cores, with grades, stages and Gleason scores
(No reviews yet)
Write a Review
- SKU:
- 131-PR481-GEN
- Availability:
- IN STOCK
Description
Prostate cancer tissue array with unmatched normal prostate tissues, 24 cases/48 cores, with grades, stages and Gleason scores
Related Products
Prostate cancer with normal prostate tissue array, including TNM, pathology grade, Gleason grade and gleason score, 24cases/48 cores, replaced by PR482b
131
£614.00
Prostate cancer with normal prostate tissue array, including TNM, pathology grade, Gleason grade and gleason score, 24cases/48 cores, replaced by PR482b
131-PR482a-GEN
Prostate cancer with normal tissue array, including pathology grade, Gleason grade, Gleason score, TNM and clinical stage, 48 cases/48 cores, replacing PR483b
131
£614.00
Prostate cancer with normal tissue array, including pathology grade, Gleason grade, Gleason score, TNM and clinical stage, 48 cases/48 cores, replacing PR483b
131-PR483c-GEN
Prostate cancer with adjacent normal tissue and normal tissue array, including pathology grade, Gleason grade, Gleason score, TNM and clinical stage, 96 cases/192 cores, replacing PR1921b
131
£1,284.00
Prostate cancer with adjacent normal tissue and normal tissue array, including pathology grade, Gleason grade, Gleason score, TNM and clinical stage, 96 cases/192 cores, replacing PR1921b
131-PR1921c-GEN
Prostate cancer, hyperplasia with normal tissue array, including pathology grade, Gleason grade, Gleason score, TNM and clinical stage, 21cases/63 cores
131
£798.00
Prostate cancer, hyperplasia with normal tissue array, including pathology grade, Gleason grade, Gleason score, TNM and clinical stage, 21cases/63 cores
131-PR632-GEN
Prostate cancer with normal tissue array, including WHO grade, Gleason grade, Gleason score, TNM and clinical stage, 40 cases/80 cores, replacing PR808
131
£798.00
Prostate cancer with normal tissue array, including WHO grade, Gleason grade, Gleason score, TNM and clinical stage, 40 cases/80 cores, replacing PR808
131-PR808a-GEN